# Chinese Rheumatism Biobank(CRB)

> **NCT06887517** · — · RECRUITING · sponsor: **Chinese SLE Treatment And Research Group** · enrollment: 300 (estimated)

## Conditions studied

- Lupus Erythematosus, Systemic

## Interventions

- **DRUG:** Antimalarial with or without oral glucocorticosteroid

## Key facts

- **NCT ID:** NCT06887517
- **Lead sponsor:** Chinese SLE Treatment And Research Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-10
- **Primary completion:** 2028-04-01
- **Final completion:** 2033-04-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06887517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06887517, "Chinese Rheumatism Biobank(CRB)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06887517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*